$VERO News

Last published 3mo ago

3mo agoVEROVenus Concept Obtains Exclusive Distribution Rights for the HIRONIC Doublo 2.0 Device in US and CanadaGlobeNewswireTORONTO, July 28, 2026 (GLOBE NEWSWIRE) -- Venus Concept Inc. ("Venus Concept" or the "Company"), a global medical aesthetic technology leader, today announced it has entered into an exclusive
6mo agoVEROVenus Concept Announces Senior Management ChangesGlobeNewswireTORONTO, May 13, 2026 (GLOBE NEWSWIRE) -- Venus Concept Inc. ("Venus Concept" or the "Company"), a global medical aesthetic technology leader, today announced changes to its senior leadership team. Kirk Gunhus, Chief
7mo agoVEROVenus Concept Announces Completion of Common Stock Sale and Short-Form MergerGlobeNewswireTORONTO, April 01, 2026 (GLOBE NEWSWIRE) -- Venus Concept Inc. ("Venus Concept" or the "Company"), a global medical aesthetic technology leader, today announced the successful completion by affiliates of Madryn Asset
9mo agoVEROVenus Concept Announces Intention to Voluntary Delist from Nasdaq and Deregister with SECGlobeNewswireTORONTO, Jan. 21, 2026 (GLOBE NEWSWIRE) -- Venus Concept Inc. ("Venus Concept" or the "Company") announced today its voluntarily decision to delist its common stock from the NASDAQ Capital Market ("Nasdaq") and
12mo agoVEROVenus Concept Announces Third Quarter 2025 Financial ResultsGlobeNewswireTORONTO, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. ("Venus Concept" or the "Company") (NASDAQ:VERO), a global medical aesthetic technology leader, announced financial results for the three and nine months
1y agoVEROVenus Concept Receives 510(k) for the Venus NOVA, Its Most Advanced Multi-Application Platform for Non-Invasive Body and Skin TreatmentsGlobeNewswireTORONTO, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. ("Venus Concept" or the "Company"), a global leader in medical aesthetic technology, announced today that it has received a 510(k) clearance from the U.S.
1y agoVEROVenus Concept Announces $11.48 Million Debt-to-Equity Exchange TransactionGlobeNewswireTORONTO, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. ("Venus Concept" or the "Company") (NASDAQ:VERO), a global medical aesthetic technology leader, announced today that, on September 30, 2025, the Company
1y agoVEROVenus Concept to Release Third Quarter of Fiscal Year 2025 Financial Results on November 13, 2025GlobeNewswireTORONTO, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. ("Venus Concept" or the "Company") (NASDAQ:VERO), a global medical aesthetic technology leader, announced today that third quarter of fiscal year 2025
1y agoVEROVenus Concept Inc. (VERO) Q2 2025 Earnings Call TranscriptEarnings Call Transcripts
1y agoVEROVenus Concept Announces Second Quarter 2025 Financial ResultsGlobeNewswireTORONTO, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. ("Venus Concept" or the "Company") (NASDAQ:VERO), a global medical aesthetic technology leader, announced financial results for the three and six months
1y agoVEROVenus Concept to Release Second Quarter of Fiscal Year 2025 Financial Results on August 14, 2025GlobeNewswireTORONTO, July 16, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. ("Venus Concept" or the "Company") (NASDAQ:VERO), a global medical aesthetic technology leader, announced today that second quarter of fiscal year 2025
1y agoVEROVenus Concept Announces $6.5 Million Debt-to-Equity Exchange TransactionGlobeNewswireTORONTO, July 01, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. ("Venus Concept" or the "Company") (NASDAQ:VERO), a global medical aesthetic technology leader, announced today that, on June 30, 2025, the Company
1y agoVEROVenus Concept Announces Closing of Up To $3.45 Million Registered Direct Offering Priced At-The-Market Under Nasdaq RulesGlobeNewswireTORONTO, June 09, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. ("Venus Concept" or the "Company") (NASDAQ:VERO), a global medical aesthetic technology leader, today announced the closing of its previously announced
1y agoVEROVenus Concept Announces Up To $3.45 Million Registered Direct Offering Priced At-The-Market Under Nasdaq RulesGlobeNewswireTORONTO, June 06, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. ("Venus Concept" or the "Company") (NASDAQ:VERO), a global medical aesthetic technology leader, today announced that it has entered into definitive
1y agoVEROVenus Concept Announces Definitive Agreement to Sell Venus Hair Business for $20 MillionGlobeNewswireTORONTO, June 06, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. ("Venus Concept" or the "Company") (NASDAQ:VERO), a global medical aesthetic technology leader, announced today it has entered into a definitive agreement
1y agoVEROVenus Concept Announces First Quarter 2025 Financial ResultsGlobeNewswireTORONTO, May 15, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. ("Venus Concept" or the "Company") (NASDAQ:VERO), a global medical aesthetic technology leader, announced financial results for the three months ended March
1y agoVEROVenus Concept Raises a Total of Approximately $2.7 Million in Gross Proceeds from Previously Announced Registered Direct Offerings of Common StockGlobeNewswireTORONTO, April 14, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. ("Venus Concept" or the "Company") (NASDAQ:VERO), a global medical aesthetic technology leader, today announced the closing of its previously announced
1y agoVEROVenus Concept Announces $1.5 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq RulesGlobeNewswireTORONTO, April 11, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. ("Venus Concept" or the "Company") (NASDAQ:VERO), a global medical aesthetic technology leader, today announced that it has entered into definitive
1y agoVEROVenus Concept Announces Closing of $1.1 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq RulesGlobeNewswireTORONTO, April 10, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. ("Venus Concept" or the "Company") (NASDAQ:VERO), a global medical aesthetic technology leader, today announced the closing of its previously announced
1y agoVEROVenus Concept Announces $1.1 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq RulesGlobeNewswireTORONTO, April 09, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. ("Venus Concept" or the "Company") (NASDAQ:VERO), a global medical aesthetic technology leader, today announced that it has entered into definitive
1y agoVEROVenus Concept to Release First Quarter of Fiscal Year 2025 Financial Results on May 15, 2025GlobeNewswireTORONTO, April 07, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. ("Venus Concept" or the "Company") (NASDAQ:VERO), a global medical aesthetic technology leader, announced today that first quarter of fiscal year 2025
1y agoVEROVenus Concept Announces $11 million Debt-to-Equity Exchange TransactionGlobeNewswireTORONTO, April 01, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. ("Venus Concept" or the "Company") (NASDAQ:VERO), a global medical aesthetic technology leader, announced today that, on March 31, 2025, the Company
1y agoVEROVenus Concept Announces Fourth Quarter and Fiscal Year 2024 Financial ResultsGlobeNewswireTORONTO, March 31, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. ("Venus Concept" or the "Company") (NASDAQ:VERO), a global medical aesthetic technology leader, announced financial results for the three and twelve months
1y agoVEROVenus Concept to Release Fourth Quarter and Fiscal Year 2024 Financial Results on March 31, 2025GlobeNewswireTORONTO, March 03, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. ("Venus Concept" or the "Company") (NASDAQ:VERO), a global medical aesthetic technology leader, announced today that fourth quarter and fiscal year 2024
1y agoVEROVenus Concept Announces 1-for-11 Reverse Stock SplitGlobeNewswireTORONTO, Feb. 27, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. ("Venus Concept" or the "Company") (NASDAQ:VERO), a global medical aesthetic technology leader, today announced that it will effect a 1-for-11 reverse stock
1y agoVEROVenus Concept Announces Senior Management ChangesGlobeNewswireTORONTO, Feb. 25, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. ("Venus Concept" or the "Company") (NASDAQ:VERO), a global medical aesthetic technology leader, today announced several changes to its senior leadership
1y agoVEROVenus Concept Inc. (VERO) Q3 2024 Earnings Call TranscriptEarnings Call Transcripts
1y agoVEROVenus Concept Announces Third Quarter of Fiscal Year 2024 Financial ResultsGlobeNewswireTORONTO, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. ("Venus Concept" or the "Company") (NASDAQ:VERO), a global medical aesthetic technology leader, announced financial results for the three and nine months
2y agoVEROVenus Concept Announces Expansion of International Distribution Network and Certification of Products in IndiaGlobeNewswireTORONTO, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. ("Venus Concept" or the "Company") (NASDAQ:VERO), a global medical aesthetic technology leader, announced the continued expansion of its international
2y agoVEROVenus Concept to Release Third Quarter of Fiscal Year 2024 Financial Results on November 13, 2024GlobeNewswireTORONTO, Oct. 02, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. ("Venus Concept" or the "Company") (NASDAQ:VERO), a global medical aesthetic technology leader, announced today that third quarter of fiscal year 2024
2y agoVEROVenus Concept Announces $15 million Debt-to-Equity Exchange TransactionGlobeNewswireTORONTO, Sept. 27, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. ("Venus Concept" or the "Company") (NASDAQ:VERO), a global medical aesthetic technology leader, today announced that, on September 26, 2024, the Company
2y agoVEROVenus Concept Announces Australian Regulatory Approval for Venus Bliss MAXGlobeNewswireTORONTO, Sept. 18, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. ("Venus Concept" or the "Company") (NASDAQ:VERO), a global medical aesthetic technology leader, today announced that it has clearance from the Therapeutic
2y agoVEROVenus Concept Inc. (VERO) Q2 2024 Earnings Call TranscriptEarnings Call Transcripts
2y agoVEROVenus Concept Announces Second Quarter of Fiscal Year 2024 Financial ResultsGlobeNewswireTORONTO, Aug. 13, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. ("Venus Concept" or the "Company") (NASDAQ:VERO), a global medical aesthetic technology leader, announced financial results for the three and six months
2y agoVEROVenus Concept Announces Regulatory Approval for Venus Bliss MAX in CanadaGlobeNewswireTORONTO, July 29, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. ("Venus Concept" or the "Company") (NASDAQ:VERO), a global medical aesthetic technology leader, today announced that it has received a medical device
2y agoVEROVenus Concept to Release Second Quarter of Fiscal Year 2024 Financial Results on August 13, 2024GlobeNewswireTORONTO, July 15, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. ("Venus Concept" or the "Company") (NASDAQ:VERO), a global medical aesthetic technology leader, announced today that second quarter of fiscal year 2024
2y agoVEROVenus Concept Celebrates Successful Completion of its NEXThetics Events Across North AmericaGlobeNewswireTORONTO, June 27, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. ("Venus Concept" or the "Company") (NASDAQ:VERO), a global medical aesthetic technology leader, announces the successful completion of its
2y agoVEROVenus Concept Announces Exclusive Strategic Supply Arrangement with Skin LaundryGlobeNewswireTORONTO, June 17, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. ("Venus Concept" or the "Company") (NASDAQ:VERO), a global medical aesthetic technology leader, announced today that it has entered a new
2y agoVEROVenus Concept Regains Compliance with Nasdaq's Minimum Equity RequirementGlobeNewswireTORONTO, June 06, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. ("Venus Concept" or the "Company") (NASDAQ:VERO), a global medical aesthetic technology leader, announced that on June 4, 2024, it was notified by the
2y agoVEROVenus Concept Announces Approval for Venus Versa Pro in CanadaGlobeNewswireTORONTO, June 03, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. ("Venus Concept" or the "Company") (NASDAQ:VERO), a global medical aesthetic technology leader, today announced that it has received a medical device
2y agoVEROVenus Concept Announces $35 million Debt-to-Equity Exchange TransactionGlobeNewswireTORONTO, May 28, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. ("Venus Concept" or the "Company") (NASDAQ:VERO), a global medical aesthetic technology leader, today announced that, on May 24, 2024, the Company exchanged
2y agoVEROVenus Concept Inc. (VERO) Q1 2024 Earnings Call TranscriptEarnings Call Transcripts
2y agoVEROVenus Concept Announces First Quarter of Fiscal Year 2024 Financial ResultsGlobeNewswireTORONTO, May 15, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. ("Venus Concept" or the "Company") (NASDAQ:VERO), a global medical aesthetic technology leader, announced financial results for the three months ended March
2y agoVEROVenus Concept Announces Loan Purchase and Completion of First Phase of RefinancingGlobeNewswireTORONTO, April 24, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. ("Venus Concept" or the "Company") (NASDAQ:VERO), a global medical aesthetic technology leader, today announced that on April 23, 2024, its existing Main
2y agoVEROVenus Concept to Release First Quarter of Fiscal Year 2024 Financial Results on May 15, 2024GlobeNewswireTORONTO, April 15, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. ("Venus Concept" or the "Company") (NASDAQ:VERO), a global medical aesthetic technology leader, announced today that first quarter of fiscal year 2024
2y agoVEROVenus Concept Announces Israeli Regulatory Approval for Venus Bliss MAXGlobeNewswireTORONTO, April 08, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. ("Venus Concept" or the "Company") (NASDAQ:VERO), a global medical aesthetic technology leader, today announced that it has received approval for the Venus
2y agoVEROVenus Concept Announces Australian Regulatory Approval for Venus Versa ProGlobeNewswireTORONTO, April 03, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. ("Venus Concept" or the "Company") (NASDAQ:VERO), a global medical aesthetic technology leader, today announced that it has Therapeutic Goods
2y agoVEROVenus Concept Inc. (VERO) Q4 2023 Earnings Call TranscriptEarnings Call Transcripts
2y agoVEROVenus Concept Announces Fourth Quarter and Fiscal Year 2023 Financial ResultsGlobeNewswireTORONTO, April 01, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. ("Venus Concept" or the "Company") (NASDAQ:VERO), a global medical aesthetic technology leader, announced financial results for the three and twelve
2y agoVEROVenus Concept Granted Continued Listing from Nasdaq Hearings Panel, Subject to Return to Compliance with Nasdaq Listing RulesGlobeNewswireTORONTO, March 25, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. ("Venus Concept" or the "Company") (NASDAQ:VERO) announced today that it received a decision from the Nasdaq Hearings Panel (the "Nasdaq Panel") granting